Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Thomas G. Brott, M.D.


Photo of Thomas G. Brott, M.D.
Professor of Neurology, Mayo Clinic 
James C. and Sarah K. Kennedy Dean for Research, Mayo Clinic in Florida 

Thomas G. Brott, M.D., is Professor of Neurology, Mayo Clinic and James C. and Sarah K. Kennedy Dean for Research, Mayo Clinic in Florida. In addition, he is adjunct professor in the Department of Surgery at the University of Medicine and Dentistry of New Jersey in Newark, N.J. A pioneer in the field of stroke and cerebrovascular disease research, Dr. Brott was a leading investigator in the studies that identified tissue plasminogen activator (t-PA) as an effective acute treatment for ischemic stroke. He also played a key role in designing the National Institutes of Health Stroke Scale (NIHSS). Currently, Dr. Brott is principal investigator for the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) and national co-principal investigator of the Siblings with Ischemic Stroke Study (SWISS), both funded by NINDS. Dr. Brott received his M.D. from the University of Chicago and completed his residency at the Harvard Longwood Neurology Program. He has received many awards and honors and has held several national leadership positions, including chair of the Advisory Committee to the Neurological Devices Panel of the Food and Drug Administration and chair of the Stroke Council of the American Heart Association. He is a member of numerous professional societies and is widely published in the field.


Last Modified September 20, 2012